Rebecca Sendak

Rebecca Sendak has more than 20 years of experience in biologics CMC (chemistry, manufacturing, and controls) at Genzyme and Sanofi, from cell line development through GMP drug product manufacturing. Supported the development and commercialization of several biologics currently on the market. She is also the Head (SVP) of the Global Large Molecules Research Platform at Sanofi.

Rebecca holds a Ph.D. in Biophysical Chemistry from Cornell University and received a Bachelor of Arts in Biology and Chemistry from the University of Vermont.